#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Yojana Gadiya"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/conso
# --------------------------------------------------------
# DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
 DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/757cbc1e7215da9fdd67bc73b14fbce59736cbdb/export/conso-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
 DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
# DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
 DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns"
 DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
 DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
# DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
# DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
# DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
# DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
# DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
# DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
 DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
# DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
# DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
 DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
 DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
 DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
# DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
# DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "25478017"}

#experiments done in rats using human tau peptide
SET Species = "10116"
#cell line - SHR72
SET MeSHDisease = "Alzheimer Disease"

SET Evidence = "Importantly, the analysed antibodies
showed statistically significantly higher binding activity to
the tau peptide and to mis-disordered tau 150-391/4R, than
to physiological tau 2N4R (P = 0.0003 and P = 0.0028,
respectively) (Figure 1B)."
SET Confidence = "High"
#cysteinated tau peptide C-294KDNIKHVPGGGS305
#antibody - synthetic tau peptide AADvac1
a(CONSO:AADvac1) => complex(a(CONSO:AADvac1),p(CONSO:"Tau isoform F (441 aa)",frag("?")))
a(CONSO:AADvac1) => complex(a(CONSO:AADvac1),p(CONSO:"4R tau",var("p.151_391del")))
a(CONSO:AADvac1) => complex(a(CONSO:AADvac1),p(CONSO:"Tau isoform F (441 aa)"))
UNSET Confidence

SET Evidence = "Vaccination with tau vaccine
carrying DC8E8 epitope induced antibodies preferentially
recognising mis-disordered tau protein, thus discriminating
between pathological and physiological tau."
SET Confidence = "High"
complex(a(CONSO:AADvac1),a(CONSO:DC8E8)) -> complex(GO:"immunoglobulin complex")
complex(GO:"immunoglobulin complex") pos complex(complex(GO:"immunoglobulin complex"),p(CONSO:"4R tau",var("p.151_391del")))
UNSET Confidence

SET Evidence = "Vaccination of
rats with the tau peptide vaccine preferentially induced formation
of IgG1 antibody isotypes specific to mis-disordered
tau (151-391/4R) (Figure 1C), indicating a predominant
type 2 helper T cell (Th2) type of immune response."
SET Confidence = "High"
p(CONSO:"Tau isoform F (441 aa)",frag("?")) -> p(MESH:"Immunoglobulin G")
p(MESH:"Immunoglobulin G") -> complex(p(MESH:"Immunoglobulin G"),p(CONSO:"4R tau",var("p.151_391del")))
bp(GO:"T-helper 2 cell activation") -> complex(a(MESH:"Immunoglobulin G"),p(CONSO:"4R tau",var("p.151_391del")))
UNSET Confidence

SET Evidence = "Immunisation with tau vaccine induced
significant reduction of the level of highly phosphorylated
forms of truncated tau (30 to 36 kDa), tau oligomers
(above 36 kDa) and full-length tau (above 43 kDa)
revealed by measurement with pan-tau monoclonal antibody
DC25 (P = 0.0322) (Figure 2A and F)."
#detected with help of pan-tau monoclonal antibody
SET Confidence = "High"
a(CONSO:AADvac1) =| p(HGNC:MAPT,frag("?"),pmod(CONSO:hyperphosphorylation))
a(CONSO:AADvac1) =| p(CONSO:"Tau oligomers")
a(CONSO:AADvac1) =| p(HGNC:MAPT)
UNSET Confidence

SET Evidence = "Moreover,
analysis with phospho-dependent monoclonal antibodies
revealed significant reduction of the levels of insoluble
tau species phosphorylated at Thr217 (pThr217, P =
0.0094; Figure 2B and F), pThr231 (DC209, P = 0.0077;
Figure 2C and F), pSer202/pThr205 (AT8, P = 0.0112;
Figure 2D and F) and pThr181 (DC179, P = 0.0100; Figure 2E
and F)."
SET Confidence = "High"
a(CONSO:AADvac1) =| p(HGNC:MAPT,pmod(Ph,Thr,217))
a(CONSO:AADvac1) =| p(HGNC:MAPT,pmod(Ph,Thr,231))
a(CONSO:AADvac1) =| p(HGNC:MAPT,pmod(Ph,Ser,202))
a(CONSO:AADvac1) =| p(HGNC:MAPT,pmod(Ph,Thr,205))
a(CONSO:AADvac1) =| p(HGNC:MAPT,pmod(Ph,Thr,181))
UNSET Confidence

SET Evidence = "These results show that the immunisation
significantly reduced early forms of pathological tau
(represented by monomers, dimers and oligomers) and late
forms of pathological tau polymers (represented by paired
helical filaments (PHFs)) as well."
SET Confidence = "High"
a(CONSO:AADvac1) -| path(MESH:Tauopathies)
a(CONSO:AADvac1) -| complex(p(HGNC:MAPT),p(HGNC:MAPT))
a(CONSO:AADvac1) -| complex(p(HGNC:MAPT),p(HGNC:MAPT),p(HGNC:MAPT))
a(CONSO:AADvac1) -| p(CONSO:"Tau oligomers")
complex(p(HGNC:MAPT),p(HGNC:MAPT)) -> path(MESH:Tauopathies)
complex(p(HGNC:MAPT),p(HGNC:MAPT),p(HGNC:MAPT)) -> path(MESH:Tauopathies)
p(CONSO:"Tau oligomers") -> path(MESH:Tauopathies)
a(CONSO:AADvac1) -| a(CONSO:"paired helical filaments")
UNSET Confidence

SET Species = "10116"

 SET Evidence = "We
found that several monoclonal antibodies, including
TAU5 (part A in Additional file 2), HT7 (B in Additional
file 2), pT212 (C in Additional file 2) and pS214 (D in
Additional file 2), recognised neurofibrillary degeneration
in transgenic rat brain."
SET Confidence = "High"
SET MeSHAnatomy = "Brain"
a(CONSO:"Tau antibody, HT7") -> complex(a(CONSO:"Tau antibody, HT7"),a(CONSO:"Tau fibrils"))
p(HGNC:MAPT,pmod(Ph,Thr,212)) -> complex(p(HGNC:MAPT,pmod(Ph,Thr,212)),a(CONSO:"Tau fibrils"))
p(HGNC:MAPT,pmod(Ph,Ser,214)) -> complex(p(HGNC:MAPT,pmod(Ph,Ser,214)),a(CONSO:"Tau fibrils"))
UNSET MeSHAnatomy
UNSET Confidence

SET Evidence = "Immunostaining with AT8,
pT212 and pS214 showed that immunisation reduced
the number of transgenic rats with extensive neurofibrillary
degeneration by 55% (AT8, pT212; Figure 3C
and F) or by 77% (pS214; Figure 3I)."
SET Confidence = "High"
p(CONSO:"Tau epitope, AT8") -| a(CONSO:"Tau fibrils")
p(HGNC:MAPT,pmod(Ph,Thr,212)) -| a(CONSO:"Tau fibrils")
p(HGNC:MAPT,pmod(Ph,Ser,214)) -| a(CONSO:"Tau fibrils")
UNSET Confidence

SET Evidence = "The immunisation
significantly improved the total NeuroScale score of the
rats treated with tau vaccine compared to the control
treatment group (P = 0.047, Figure 4C)."
#sensorimotor function improvement
SET Confidence = "High"
a(CONSO:AADvac1) neg path(HP:"Sensorimotor neuropathy")
UNSET Confidence

SET Evidence = "To assess possible negative impacts on the immune system,
thorough haematological analysis was conducted in
acute and chronic toxicology studies in rats and rabbits,
respectively. The haematology panel featured the following
assessments: erythrocyte count, haemoglobin, haematocrit,
mean corpuscular volume, red-cell volume distribution
width, mean corpuscular haemoglobin, mean corpuscular
haemoglobin concentration, haemoglobin concentration
distribution width, reticulocyte count, reticulocyte maturity
index, platelet (thrombocyte) count, total leukocyte
count, differential leukocyte count (neutrophils, lymphocytes,
monocytes, eosinophils, basophils, large unstained
cells). Both absolute numbers and relative amounts of
white blood cells were assessed. The vaccination did not
induce any toxicologically relevant effect on any of the observed
parameters."
SET Confidence = "High"
a(CONSO:AADvac1) cnc path(MESH:"Erythrocyte Count")
a(CONSO:AADvac1) cnc complex(GO:"hemoglobin complex")
a(CONSO:AADvac1) cnc path(MESH:"Erythrocyte Indices")
a(CONSO:AADvac1) cnc path(MESH:"Reticulocyte Count")
a(CONSO:AADvac1) cnc path(MESH:"Platelet Count")
a(CONSO:AADvac1) cnc path(MESH:"Leukocyte Count")
UNSET Confidence
UNSET Species
